• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,808.48 544.15
( 0.71%)
Global Indices
Nasdaq
51,705.57 482.31
(0.94%)
Dow Jones
7,575.20 122.74
(1.65%)
Hang Seng
69,393.70 76.20
(0.11%)
Nikkei 225
10,504.45 73.83
(0.71%)
Forex
USD-INR
94.92 -0.57
(-0.60%)
EUR-INR
109.83 -0.42
(-0.38%)
GBP-INR
127.25 -0.49
(-0.38%)
JPY-INR
0.59 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Esaar (India) Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
531502
INE404L01039
19.3481717
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
2.19
24.45
EPS(TTM)
Face Value()
Div & Yield %
5.45
10
0
 

suven life sciences ltd
Board of Zydus Lifesciences approves share buyback of Rs 1,100 cr
May 19,2026
The board of Zydus Lifesciences at its meeting held on 19 May 2026 has approved the proposal to buyback up to 95,65,217 fully paid up equity shares of the company at a price of Rs 1,150 per equity share payable in cash for an aggregate amount not exceeding Rs 1100 crore.